- XV Eurasian Hematology-Oncology Congress - EHOC 2024
- XIV Eurasian Hematology-Oncology Congress - EHOC 2023
- 8th Eurasian Hematology Oncology Summit
- XIth Eurasian Hematology-Oncology Congress - EHOC 2020
- 7th Eurasian Hematology Oncology Summit
- Xth Eurasian Hematology-Oncology Congress
- Events
Playback speed
10 seconds
Postoperative Adjuvant Therapy Options in Head&Neck Cancer: Concurrent Chemoradiation in High Risk Patients & Immunotherapy as a Future Possibility
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Musa Altun
By
Xth Eurasian Hematology-Oncology Congress
FEATURING
Musa Altun
0 views
November 12, 2019
Comments 0
Login to view comments.
Click here to Login
Head & Neck